Lipitor Trial To Study The Effect Of Torcetrpib/Atorvastatin To Atorvastatin Alone.

Completed · Phase 3

Conditions studied: Hyperlipidemia

In brief

The Torcetrapib project was terminated on December 2, 2006 due to safety findings. To look at various lipids in the blood of people with Fredrickson Type IIa and Type IIb mixed dyslipidemias

Key facts

Study ID

NCT00137462

Run by

Pfizer

People needed

900

Starts

2004-11-01

Expected to finish

2006-09-01

Last updated by the study team

2007-11-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Statin eligible per NCEP ATP-III guidelines
• At least 18 years of age

You may not qualify if…

• Women who are pregnant or lactating, or planning to become pregnant
• Intolerance to statin therapy
• Subjects taking any drugs known to be associated with an increased risk of myositis in combination with HMG-CoA reductase inhibitors
• Subjects with any other medical condition or laboratory abnormality which could affect subject safety, preclude evaluation of response, or render unlikely that the subject would complete the study

Where it is running

• Pfizer Investigational Site — Union Grove, Alabama, United States
• Pfizer Investigational Site — Fresno, California, United States
• Pfizer Investigational Site — Los Angeles, California, United States
• Pfizer Investigational Site — Orange, California, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — Denver, Colorado, United States
• Pfizer Investigational Site — Denver, Colorado, United States
• Pfizer Investigational Site — Golden, Colorado, United States
• Pfizer Investigational Site — Bridgeport, Connecticut, United States
• Pfizer Investigational Site — Fairfield, Connecticut, United States
• Pfizer Investigational Site — Trumbull, Connecticut, United States
• Pfizer Investigational Site — Waterbury, Connecticut, United States
• Pfizer Investigational Site — Washington D.C., District of Columbia, United States
• Pfizer Investigational Site — Boynton Beach, Florida, United States
• Pfizer Investigational Site — Fort Lauderdale, Florida, United States
• Pfizer Investigational Site — Gainesville, Florida, United States
• Pfizer Investigational Site — Gainesville, Florida, United States
• Pfizer Investigational Site — Gainsville, Florida, United States
• Pfizer Investigational Site — Sebastian, Florida, United States
• Pfizer Investigational Site — Vero Beach, Florida, United States
• Pfizer Investigational Site — Rockford, Illinois, United States
• Pfizer Investigational Site — Springfield, Illinois, United States
• Pfizer Investigational Site — Olathe, Kansas, United States
• Pfizer Investigational Site — Overland Park, Kansas, United States
• Pfizer Investigational Site — Huntsville, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.